These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 39417096)

  • 1. Predictive Value of V̇O
    Soares A; Park LK; Mansour E; Deych E; Puritz A; Zhao M; Cao C; Coggan AR; Barger PM; Foraker R; Racette SB; Peterson LR
    medRxiv; 2024 Oct; ():. PubMed ID: 39417096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Cardiovascular Reserve in Chronic Kidney Failure: A Matched Cohort Study.
    Ting SM; Hamborg T; McGregor G; Oxborough D; Lim K; Koganti S; Aldridge N; Imray C; Bland R; Fletcher S; Krishnan NS; Higgins RM; Townend J; Banerjee P; Zehnder D
    Am J Kidney Dis; 2015 Aug; 66(2):274-84. PubMed ID: 25900597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of VO 2peak on the Clinical Outcomes of Older Patients With Coronary Heart Disease in China.
    Zhang YY; Liu XL; Hu X; Hu R; Xu Y; Ma J
    J Cardiopulm Rehabil Prev; 2024 Sep; 44(5):339-344. PubMed ID: 39185916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in clinical profile, left ventricular remodeling and cardiovascular outcomes among diabetic patients with heart failure and reduced ejection fraction: a cardiac-MRI-based study.
    Shi K; Zhang G; Fu H; Li XM; Jiang L; Gao Y; Qian WL; Shen LT; Xu HY; Li Y; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2024 Jul; 23(1):266. PubMed ID: 39039567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiopulmonary exercise testing as prognostic indicators: Comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction.
    Sato T; Yoshihisa A; Kanno Y; Suzuki S; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Ishida T; Takeishi Y
    Eur J Prev Cardiol; 2017 Dec; 24(18):1979-1987. PubMed ID: 29086584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum.
    Jones LW; Courneya KS; Mackey JR; Muss HB; Pituskin EN; Scott JM; Hornsby WE; Coan AD; Herndon JE; Douglas PS; Haykowsky M
    J Clin Oncol; 2012 Jul; 30(20):2530-7. PubMed ID: 22614980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Hemodynamic Gain Index in Patients With Heart Failure With Reduced Ejection Fraction.
    Chaikijurajai T; Finet JE; Engelman T; Wu Y; Martens P; Van Iterson E; Morales-Oyarvide V; Grodin JL; Tang WHW
    JACC Heart Fail; 2024 Feb; 12(2):261-271. PubMed ID: 37318421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of cardiac transplantation in patients with heart failure receiving beta-adrenergic blockers.
    Peterson LR; Schechtman KB; Ewald GA; Geltman EM; de las Fuentes L; Meyer T; Krekeler P; Moore ML; Rogers JG
    J Heart Lung Transplant; 2003 Oct; 22(10):1141-8. PubMed ID: 14550824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of a new cardiopulmonary exercise testing parameter in chronic heart failure: oxygen uptake efficiency at peak exercise - comparison with oxygen uptake efficiency slope.
    Toste A; Soares R; Feliciano J; Andreozzi V; Silva S; Abreu A; Ramos R; Santos N; Ferreira L; Ferreira RC
    Rev Port Cardiol; 2011 Oct; 30(10):781-7. PubMed ID: 22118129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wait-List Outcomes for Adults With Congenital Heart Disease Listed for Heart Transplantation in the U.S.
    Alshawabkeh LI; Hu N; Carter KD; Opotowsky AR; Light-McGroary K; Cavanaugh JE; Bartlett HL
    J Am Coll Cardiol; 2016 Aug; 68(9):908-17. PubMed ID: 27561764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction.
    Liu D; Hu K; Schregelmann L; Hammel C; Lengenfelder BD; Ertl G; Frantz S; Nordbeck P
    ESC Heart Fail; 2023 Apr; 10(2):1358-1371. PubMed ID: 36732921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer.
    Jones LW; Watson D; Herndon JE; Eves ND; Haithcock BE; Loewen G; Kohman L
    Cancer; 2010 Oct; 116(20):4825-32. PubMed ID: 20597134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic impact of aortic pulsatility index on event-free survival in patients with heart failure with preserved ejection fraction].
    Wu YH; Zhang YH; Zhang J
    Zhonghua Yi Xue Za Zhi; 2024 Feb; 104(8):594-599. PubMed ID: 38389237
    [No Abstract]   [Full Text] [Related]  

  • 14. Adults With Congenital Heart Disease: Trends in Event-Free Survival Past Middle Age.
    Dellborg M; Giang KW; Eriksson P; Liden H; Fedchenko M; Ahnfelt A; Rosengren A; Mandalenakis Z
    Circulation; 2023 Mar; 147(12):930-938. PubMed ID: 36571845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse myocardial fibrosis and the prognosis of heart failure with reduced ejection fraction in Chinese patients: a cohort study.
    Li F; Xu M; Fan Y; Wang Y; Song Y; Cui X; Fu M; Qi B; Han X; Zhou J; Ge J
    Int J Cardiovasc Imaging; 2020 Apr; 36(4):671-689. PubMed ID: 31893323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitive troponin T and N-terminal pro-B-type natriuretic peptide independently predict survival and cardiac-related events in adults with congenital heart disease.
    Willinger L; Brudy L; Häcker AL; Meyer M; Hager A; Oberhoffer-Fritz R; Ewert P; Müller J
    Eur J Cardiovasc Nurs; 2024 Jan; 23(1):55-61. PubMed ID: 36883916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction.
    Nadruz W; West E; Sengeløv M; Santos M; Groarke JD; Forman DE; Claggett B; Skali H; Shah AM
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29089342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of exercise therapy on cardiorespiratory fitness in patients with schizophrenia.
    Scheewe TW; Takken T; Kahn RS; Cahn W; Backx FJ
    Med Sci Sports Exerc; 2012 Oct; 44(10):1834-42. PubMed ID: 22525773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD).
    Vehmeijer JT; Koyak Z; Leerink JM; Zwinderman AH; Harris L; Peinado R; Oechslin EN; Robbers-Visser D; Groenink M; Boekholdt SM; de Winter RJ; Oliver JM; Bouma BJ; Budts W; Van Gelder IC; Mulder BJM; de Groot JR
    Heart Rhythm; 2021 May; 18(5):785-792. PubMed ID: 33465514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of non-invasive measurement of cardiac output during sub-maximal exercise to predict outcome in patients with chronic heart failure.
    Goda A; Lang CC; Williams P; Jones M; Farr MJ; Mancini DM
    Am J Cardiol; 2009 Dec; 104(11):1556-60. PubMed ID: 19932792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.